Mutations in the X-linked gene MECP2 cause the majority of Rett syndrome (RTT) cases. Two differentially spliced isoforms of exons 1 and 2 (MeCP2-e1 and MeCP2-e2) contribute to the diverse functions of MeCP2, but only mutations in exon 1, not exon 2, are observed in RTT. We previously described an isoform-specific MeCP2-e1-deficient male mouse model of a human RTT mutation that lacks MeCP2-e1 while preserving expression of MeCP2-e2. However, RTT patients are heterozygous females that exhibit delayed and progressive symptom onset beginning in late infancy, including neurologic as well as metabolic, immune, respiratory and gastrointestinal phenotypes. Consequently, we conducted a longitudinal assessment of symptom development in MeCP2-e1 mutant females and males. A delayed and progressive onset of motor impairments was observed in both female and male MeCP2-e1 mutant mice, including hind limb clasping and motor deficits in gait and balance. Because these motor impairments were significantly impacted by age-dependent increases in body weight, we also investigated metabolic phenotypes at an early stage of disease progression. Both male and female MeCP2-e1 mutants exhibited significantly increased body fat compared to sex-matched wild-type littermates prior to weight differences. Mecp2e1 -/y males exhibited significant metabolic phenotypes of hypoactivity, decreased energy expenditure, increased respiratory exchange ratio, but decreased food intake compared to wild-type. Untargeted analysis of lipid metabolites demonstrated a distinguishable profile in MeCP2-e1 female mutant liver characterized by increased triglycerides. Together, these results demonstrate that MeCP2-e1 mutation in mice of both sexes recapitulates early and progressive metabolic and motor phenotypes of human RTT.
Introduction
Mutations in the X-linked gene encoding methyl CpG-binding protein 2 (MeCP2) cause the majority of Rett syndrome (RTT) cases. The specific role for MeCP2 in the molecular pathogenesis of RTT is complex, involving multiple molecular mechanisms and cell types. MeCP2 has two alternatively spliced forms (MeCP2-e1 and MeCP2-e2), and mutations in MECP2e1 (exon 1) but not MECP2e2 (exon 2) have been linked to RTT. The two isoforms differ in their N-terminals by alterative inclusion of Mecp2 exon 2 amino acids. MeCP2-e1 contains amino acids from exons 1, 3 and 4 while MeCP2-e2 contains amino acids encoded by all four exons but utilizes an alternative start codon in exon 2, resulting in the translation of only exons 2, 3 and 4 (1) (Fig. 1A) . The vast majority of RTT mutations occur in MECP2 exons 3 and 4; however, mutations in exon 1, but not exon 2, have been identified (1) (2) (3) . MeCP2-e1 is the primary isoform expressed in the central nervous system (4) and has higher protein stability than MeCP2-e2 (5), further suggesting that MeCP2-e1 is the dominant isoform in brain. We recently demonstrated a critical role for MeCP2-e1 in the pathogenesis of RTT (5) by creating a novel mouse model based on an orthologous MeCP2-e1 translation start site mutation identified in patients with classic RTT (2,3) (Mecp2e1 -/y mice) (Fig. 1A ). This isoform-specific model lacks
MeCP2-e1 translation while preserving expression of the MeCP2-e2 isoform, allowing for the examination of the specific function of MeCP2-e1. Male Mecp2e1 -/y mice recapitulate many RTT-like neurologic deficits (5) including development of hind limb clasping, motor deficits and early lethality (5) . These findings are in contrast to a mouse model with selective deletion of exon 2 that did not show neurologic symptoms (6) . Together, the evidence suggests that MeCP2-e1 deficiency alone is sufficient to induce neurologic symptoms underlying RTT in male mice. The majority of previous work on MeCP2 mouse models of RTT has focused on Mecp2 -/y hemizygous male mice as they show early and progressive symptom onset and lethality. Previous work on female mouse models of RTT has focused primarily on heterozygous Mecp2 mutations expressed in 20-40% of all cells (7, 8) . Initial characterization of heterozygous knockout females (Mecp2 tm1.1bird-/+ ) reported delayed phenotype development until 4-6 months of age (9, 10) . Recently, more detailed work in female heterozygous mouse models has revealed mixed findings for the age of phenotype development, depending on background strain and mutation type (11) (12) (13) (14) (15) (16) . However, to date there has been limited exploration of the time course of phenotype development and no behavioral characterization of isoform-specific manipulations of MeCP2 in female mouse models. Given that RTT occurs almost exclusively in females and there is no current effective treatment, there is a great need to develop a preclinical female mouse model of RTT that recapitulates the delayed behavioral phenotypes observed in human females with RTT. While MeCP2 is most highly expressed in neurons, human female RTT patients exhibit immune, microbiome, mitochondrial and metabolic manifestations that are likely reactionary to the causal mutation and neuronal dysfunction (17) (18) (19) (20) (21) (22) (23) (24) (25) . Metabolic dysfunctions are observed in RTT patients and mouse models, but whether these are consequences of inflammation or more directly mediated by MECP2, mutation is currently unknown. While RTT girls are generally not obese, perhaps due to the inability to self-feed, they have elevated morning leptin and adiponectin serum levels (17) as well as alterations in energy balance (26) (27) (28) . Furthermore, RTT has significant commonalities with mitochondrial disorders, including elevated lactate and pyruvate in blood and cerebral spinal fluid (29) , as well as markers of oxidative damage (30) that are also seen in mouse models (31, 32) . Lipid metabolism was identified in an unbiased screen for rescue of RTT mouse phenotypes (33) and was later shown to result in metabolic alterations in RTT mice (34) . Metabolic or oxidative stress alterations have been modified in several therapeutic trials of RTT mouse models (20) , with some discrepancies by strain and age (35, 36) . Since the most promising therapeutics for RTT target metabolic pathways (37) , such as AKT/mTOR (38, 39) , oxidative stress (31, 40) and lipid metabolism (33, 41) , it is imperative to characterize developmental, metabolic and motor phenotypes in female RTT mouse models.
To address the role of MeCP2-e1 in the development of phenotypes relevant to RTT, we performed a longitudinal assessment of Mecp2e1 -/+ females and Mecp2e1 -/y male mice across development and into adulthood. We assessed developmental milestones during the first 3 weeks of life and monitored the progressive development of hind limb clasping and changes in body weight into adulthood. In addition, we performed assays examining anxiety, sociability, motor function, cognition and metabolism. A delayed and progressive onset of hind limb clasping, increased body weight and motor impairments was observed, reminiscent of the delayed symptom onset observed in females with RTT. Our findings indicate that changes in body weight and metabolism may exacerbate motor impairments in the Mecp2e1 -/+ female mice, suggesting that metabolic phenotypes may serve as a novel therapeutic avenue for RTT.
Results

Both female and male MeCP2-e1 mutant mice show an onset of hind limb-clasping phenotypes by 2 months that precede a progressive increase in body weight
To examine potential early phenotypes in Mecp2e1-deficient mice, a panel of developmental milestones was assessed across the first 21 days of life. The majority of measures showed no significant differences in mutant development compared to sex-matched wild-type littermates (Supplementary Material, Table S1 ). The two exceptions were slight delays in pinnae detachment in Mecp2e1 -/+ females and cliff avoidance in
Mecp2e1
-/y males. However, all other measures were indistinguishable from wild-type, indicating normal pre-weaning development in mutant animals. Post-weaning body weight and hind limb clasping scores were assessed weekly and showed progressive symptom development in both male and female mutants ( Fig. 2 Tables S3  and S4 ).
Female MeCP2-e1 mutant mice exhibit early motor deficits impacted by age-related body weight differences
Motor function was assessed using several different tasks including analysis of gait-, beam-and rod-walking latency and accelerating rotarod performance. Female Mecp2e1 -/+ mice showed significant impairments on several measures of gait performance ( Fig. 3) . At PND 60, mutant females showed significant impairments in stride length, hind base and paw separation. However, by PND 144 only the differences in stride length were significant. Body weight was a significant covariate for the Figure 2 . Symptom development across age in male and female MeCP2e1 mutant mice. Hind limb clasping was assessed weekly using a rating scale from 0 (no clasping) to 5 (severe). Data were analyzed using an exact binomial test that tests whether there were significantly more mutant animals with clasping scores > 0 for each time point (PND). Table S3 .
Both male and female mutant mice were examined for cognitive performance using the short-term memory version of the novel object task and novel location task (43) . Both Mecp2e1 -/+ and wild-type female mice showed a significant preference for the novel object over the familiar object and there were no differences in total exploration time or distance traveled at training or testing (Supplementary Material, Fig. S8 and Table S3 ). For the object location version of the task, Mecp2e1 -/+ mice showed a significant preference for the object in the new location and wild-type littermates showed a marginally significant (P < 0.06) preference. There was no difference between genotypes for total exploration at training or testing and no difference in total distance traveled. Together, these findings indicate intact shortterm memory for both novel objects and object locations in Mecp2e1 -/+ mice. Similarly, both male wild-type and Mecp2e1 -/y mice showed a significant preference for the novel compared to familiar object during novel object recognition testing (Supplementary Material, Fig. S8 and Table S4 ). However, Mecp2e1 -/y mice did show significantly lower overall exploration during training and higher exploration during testing compared to wild-type littermates. For the object location version of the task, wild-type males showed a significant preference for the object in the new location and Mecp2e1 -/y mice showed a marginally significant preference (P < 0.06). Again, Mecp2e1 -/y mice showed higher overall exploration of the objects during training but not during testing. Overall, these findings suggest intact learning and shortterm memory in both male and female mutant mice.
MeCP2e1 mutant males exhibit significantly increased body fat despite reduced food intake due to genotype effects on energy expenditure
Since previous studies suggest metabolic defects occur in both RTT females and Mecp2/MeCP2-deficient mouse models (20,31,34,44) and because of the progressive elevated body weight in MeCP2-e1 mutant mice, we sought to better characterize the metabolic phenotypes at an early stage of disease progression (PND 57-66 in males and PND 88-92 in females) when no significant differences in body weight were observed by analysis of variance (ANOVA) for this cohort (Supplementary Material, Fig. S10 ). Dual-energy X-ray absorptiometry (DEXA) was performed to measure fat mass and bone mineral density (BMD) and area. DEXA scans revealed that both Mecp2e1 -/y males and
Mecp2e1
-/+ females had elevated percent fat ( Fig. 5A and B) and elevated fat mass ( Fig. 5C and D) . Mecp2e1 -/y mice had elevated percent fat and fat mass compared to wild-type male littermates, and Mecp2e1 -/+ mice had elevated percent fat and fat mass compared to wild-type female littermates. These differences in Mecp2e1-deficient mice were surprising as weights were similar between Mecp2e1 -/y and controls ( 
Mecp2e1 -/ + (N = 11) and Mecp2e1 +/+ (N = 12) were analyzed. P-values were computed using an unpaired, two-tailed student's t-test. * P < 0.05.
To identify potential causes of the increased fat mass and progressive increase in body weights, food intake, energy expenditure, respiratory exchange ratio (RER) and physical activity of Mecp2e1-deficient mice were measured using a Comprehensive Lab Animal Monitoring System (CLAMS Fig. S13B ). To determine the relationship between metabolism and physical activity, the total number of X-axis and X-axis ambulatory beam breaks was compared across Mecp2e1 genotypes (Fig. 7) . Mecp2e1 -/y males showed reduced locomotion compared to wild-type littermates as shown by significant reductions in X-axis beam breaks (Fig. 7A ) and X-axis ambulation (Fig. 7C) . Mecp2e1 -/+ females showed a trend towards lower levels of activity, although the effect was not significant (Fig. 7B and D) . The overall reduction in Mecp2e1 -/y activity was due to reduced X-axis total activity and X-axis ambulation during the dark cycle (Supplementary Material, Fig. S14A and S14C). In contrast, Mecp2e1 -/+ females had normal X-axis total activity and X-axis ambulation during the dark cycle (Supplementary Material, Fig. S14B and S14D). RER and energy expenditure were also examined as a possible explanation for the increased fat and body weights of MeCP2-e1 mutant mice. Mecp2e1 -/y mice exhibited significantly increased RER (Fig. 8A) , representing a shift towards increased carbohydrate oxidation compared to wild-type male littermates. Energy expenditure was also significantly lower in Mecp2e1 -/y mice compared to control males (Fig. 8C) , while Mecp2e1 -/+ females were not significantly different than female controls by either measurement (Fig. 8B and 8D ). Analysis of covariance Together, these results demonstrate a significant genotype effect of fuel usage and energy expenditure in the active dark hours that, together with reduced activity, appear to predispose MeCP2-e1-deficient male mice to lipid accumulation and weight gain despite reduced food intake. and Mecp2e1 +/+ (N = 12) were analyzed. P-values were computed using an unpaired, two-tailed student's t-test. * P < 0.05. lipid abundance. Several individual lipids were significantly increased by raw P-values, although none were significant after false discovery rate (FDR) correction (Fig. 9B) . Of the top lipid differences ranked by raw P-values, triglycerides 547, 542, 565 and 512 were elevated (Fig. 9C) . Together, these results suggest that Mecp2e1 -/+ female mice have elevated triglycerides compared to their wild-type littermates.
MeCP2-e1 mutant female profiling of liver lipids demonstrates a distinct profile of triglycerides
Discussion
Mutations in MECP2 cause the majority of RTT cases and despite many years of research, we still have a limited understanding of how MeCP2 causes a regressive disease phenotype in heterozygous and mosaic females. Furthermore, there has been limited progress on how each isoform of MeCP2 (MeCP2-e1 and -e2) contributes to the diverse functions of MeCP2. This study provides some important novel findings about the specific role of MeCP2-e1 deficiency on disease progression, with a specific focus on the female phenotypes that are expected to be most important to understanding the complex pathogenesis of human RTT. First, we demonstrate that female MeCP2-e1-deficient mice show hind-clasping phenotypes at the same stage as male MeCP2-e1-deficient littermates, around 2 months of age. Second, both male and female MeCP2-e1-deficient mice exhibit significant and progressive weight gain, but at a time point later than significant differences in hind limb clasping, fat mass and metabolism were observed. Third, female MeCP2-e1-deficient mice exhibit significant motor deficits at early stages of disease progression, which are influenced by body weight differences. Lastly, we demonstrated significant Mecp2e1 genotype effects on measurements of fat mass, BMC, food intake, physical activity and energy expenditure in mice prior to the onset of weight gain, suggesting that metabolic disruptions due to MeCP2-e1 deficiency occur early in disease progression. Together, these results demonstrate a timeline of RTT-relevant phenotype progression in a mouse model of an actual RTT mutation that should be important for better understanding and treatment of human RTT. Because of the complex MeCP2 mutant/wild-type mosaicism observed in Mecp2 mutant female mice, the majority of RTT preclinical therapy trials in mice are performed only on Mecp2 null male mice lacking MeCP2 in all cells (45) (46) (47) (48) (49) (50) . Reasons cited for only testing Mecp2 null males include the obvious phenotype (death by 8-12 weeks) and the lack of confounding X-chromosome inactivation mosaicism. However, MECP2 null mutations are not seen in human RTT patients, suggesting that Mecp2 mutant mice designed from RTT-causing human mutations are more construct-relevant models (5, (51) (52) (53) . A variety of genetic models have been developed including whole exon deletions (9,10), specific DNA-binding domain deletions (14) and a variety of knock-in point and truncation mutations that model human mutations (42, (54) (55) (56) (57) (58) . The majority of these models develop deficits similar to those observed in RTT patients, including abnormal breathing, gait abnormalities, tremors, EEG abnormalities and in some cases cognitive deficits, social abnormalities and changes in anxiety behaviors (59) . However, the complete loss of MeCP2 expression and the rapid and severe deterioration in the male models do not capture the delayed onset of symptoms and mosaic inactivation patterns of MECP2 expression in RTT females. While death is the primary phenotype in male RTT mouse models, motor, respiratory, metabolic and severe gastrointestinal symptoms are more medically relevant to the variable range of phenotypes in female RTT patients, since > 70% of RTT women are still alive by age 45 35 . Our results demonstrating significant phenotypes of hind limb clasping, increased fat mass and motor deficits by 2 months of age in female MeCP2-e1-deficient mice therefore provide an important advancement to the existing literature.
Mecp2e1
-/+ females developed abnormal behaviors by 6-7 weeks of age, similar to previous observations in Mecp2 -/+ mutant females heterozygous for exons 3 and 4 deletion affecting both Mecp2 isoforms (11, 16, 60) . Motor deficits are among the most common and consistently observed phenotypes in male and female mouse (12, 16, 45, (61) (62) (63) (64) (65) (26) (27) (28) . While dietary energy intake and fecal fat loss did not differ between RTT and controls, metabolic rates during sleep and quiet awake were significantly lower (26) and morning levels of leptin and adiponectin were elevated in RTT (17) . In RTT females, involuntary motor movements can drive increased energy expenditure and may underlie some of the shifts in energy balance (26) , but increased repetitive movements do not appear sufficient to increase total daily energy expenditure (27) . RTT girls have lower levels of lean body mass but not body fat compared to healthy controls (27) . However, when compared to disabled girls with other developmental disabilities that were matched for age, height, weight and BMI, RTT girls showed a lower percentage of lean body mass, higher absolute and relative fat mass and higher levels of energy expenditure (28) . The altered body composition and energy balance observed in RTT suggest that changes in metabolism may contribute to the disorder and serve as a novel therapeutic target for RTT treatment. (34) . The genetic background or genetic mutation difference of our Mecp2e1 -/y mice on a C57BL6/J background may explain differences between studies, although the studies are consistent in showing metabolic alterations including decreased energy expenditure and increased mass in RTT mouse models. Bone defects in Mecp2 null males were previously observed in Mecp2 null mice (69) , which is consistent with our findings in MeCP2-e1-deficient mice.
In support of a possible decreased energy expenditure in RTT mouse models across genetic backgrounds, previous metabolic analyses of RTT model mice carrying the B6.129P2(C)-Mecp2tm1.1Bird/J or 'Bird' null allele have shown that Mecp2 -/+ females have elevated body weight on 129 or C57BL6/J/129 mixed backgrounds (9, 10, 16, 54, 56) . Similarly, genetic background clearly affects weight in Mecp2 null (Bird) male mice as they were underweight on a C57BL6/J background while overweight on a 129 background (9, 16) female mice did not show clear changes in either energy expenditure or food intake prior to increases in body weight in the C57BL6/J background. These results suggest that there is a gene dosage effect on metabolic phenotypes in this RTT model that is observed prior to and somewhat independent from body weight differences. More subtle but non-significant differences in food intake or energy expenditure may be responsible for the weight gain in the female mutant mice, such as the increase in triglycerides observed in Mecp2e1 -/+ liver. More comprehensive studies of additional RTT mouse models across time points for both energy expenditure and lipidomic analysis are likely needed to determine the causes of weight gain and metabolic changes in Mecp2-deficient mice.
In conclusion, our results demonstrate that MeCP2-e1 deficiency is sufficient to cause hind-clasping, motor and metabolic phenotypes in both female and male mice. Increased body weight and fat mass were due to decreased energy expenditure, not increased food intake in MeCP2-e1-deficient male mice. Female mutant MeCP2-e1 mice showed increased fat mass and altered liver lipidomics, but not altered energy expenditure or food intake. This metabolic phenotype is consistent across multiple RTT models of different genetic mutations and backgrounds and is associated with neuronal deficiency of MeCP2. Understanding how neuronal MeCP2e1 deficiency interacts with metabolism during the molecular pathogenesis of disease progression in female RTT models is therefore of critical importance to the successful design of future therapies.
Materials and Methods
Breeding and Cross-fostering. Mecp2-e1 heterozygous females (Mecp2e1 -/+ ) were maintained on a pure C57BL/6J background by breeding to wild-type C57BL/6J males (Jax strain 000664 (16) . All measures were conducted by an experimenter blind to genotype. Body weight and body length (nose to anus) were measured using a scale (grams) and ruler (cm). Pinnae detachment, ear detachment, eye opening, incisor eruption and fur development were each rated on a scale of 0 (not present) to 3 (fully present). Cliff avoidance was tested by placing each pup near the edge of a clipboard, gently nudging it towards the edge, and scoring avoidance on rating scale from 0 (no edge avoidance) to 3 (complete turning and backing away from the edge). Righting reflex was tested by placing each pup on its back, releasing it and measuring the time for it to fully flip over onto four paws for two trials on each developmental day. Failures to flip over in the righting test were recorded as a maximum score of 30 s. Grasping reflex was tested by brushing the forepaws with a cotton tipped applicator and rating the grasping reflex from 0 (none) to 3 (strong). Auditory startle was tested using a rating scale from 0 (no response) to 3 (large flinch and turn) in response to a finger snap near the pup's head. Bar holding was tested by placing each pup's front paws on a cotton tipped applicator stick and gently lifting up. Scoring consisted of a rating scale from 0 (immediate fall) to 3 (stay on and climb up). Level screen reflex was tested by placing each pup on a screen, gently pulling the tail and rating the level of resistance (0 = none to 3 = strong). Vertical screen reflex was tested by placing each pup on a screen at a 90
• angle and rating the pup's ability to remain on the screen from 0 (immediate fall) to 3 (hold on and climb to top). Negative geotaxis was tested by placing each pup, facing downwards, on a screen angled at 45
• from parallel and scored on a scale from 0 (no turning) to 3 (complete turning and climbing to the top of the screen).
Adult Behavioral Battery. Behaviors were assessed in young adult mice from PNDs 46-152 in females and PND 35-95 in males. Mice had free access to food and water and lights were maintained on a 12:12 h light/dark cycle, with all behavioral testing performed during the light portion of the cycle. All behavioral assessments were conducted by an experimenter blinded to genotype.
Body weight and Clasping Score (weekly PNDs 28-152 for females and PNDs 28-128 for males).
Weekly body weights and hind limb clasping were assessed beginning from PND 28. Hind limb clasping was rated on a scale from 0 (no clasping behavior) to 5 (both hind limbs tucked in and abdomen contracted) (16, 42) .
Elevated Plus maze (PNDs 46-47 for females and PND 35 for males).
Each mouse was individually placed in the center area of a black Plexiglas automated elevated plus maze (Med-Associates, St. Albans City, VT), under 300 lux illumination for a 5 min test session (79, 81, 82) . The entries per arm, total entries and the time spent in each arm were recorded and compared between conditions (80).
Light ↔ Dark Exploration (PNDs 49-50 for females and PND 36 for males). The light ↔ dark exploration task was performed as previously described (79) . Briefly, the automated photocellequipped apparatus was made of two Plexiglas compartments separated by a partition with a small opening. One compartment was transparent and illuminated by an overhead light (400 lux). The other compartment was made of black Plexiglas and closed on top. Each mouse was placed into the center of the light compartment and allowed to freely explore for 10 min. The number of transitions between light and dark sides and time spent in each compartment were recorded and compared between conditions.
Open Field Exploration (PNDs 53-55 for females).
Exploratory behavior was assessed in a novel open field as previously described (79) . Each mouse was placed in an automated VersaMax Animal Activity Monitoring System (AccuScan Instruments, Columbus, OH) and allowed to freely explore for 30 min. The number of horizontal and vertical beam breaks was used as a measure of horizontal and vertical activity, respectively. Total distance traveled was used as a measure of total activity. Time spent in the center of the chamber compared to along the edges was recorded and compared between conditions.
Gait Analysis (PNDs 60-61 and 144 for females, PND 65 for males).
On the day prior to analysis, all animals were habituated to restraint and paint application. On test day, each animal was restrained, and the front feet were painted with blue while the back feet were painted with red paint (Sargent Art 22-3350 Washable Paint Hazleton, PA). The mouse was then allowed to walk down a straight alleyway lined with drawing paper (Strathmore Neenah, WI). Colored footprints were analyzed for stride length (distance between successive forelimb and successive hind limb prints), hind-base (distance between the right and left hind prints), front-base (distance between right and left front prints) and paw separation (distance between the forepaw and hind paw placement) (83) . Two to three footprints were analyzed per animal.
Accelerating Rotarod (PNDs 62-64 and 140-143 for females). Animals were given three trials per day with 1 h inter-trial intervals, repeated over 3 consecutive days (79, 80) . Each trial consisted of placing the animal on the rotarod apparatus (Ugo Basile Gemonio, VA, Italy mouse accelerating rotarod) and starting the rotation at 4 revolutions per min (rpm). After the mouse was successfully walking, the rotarod was accelerated from 4-40 rpm over 5 min (79) . The latency to fall from the rotating beam to the flange on the floor of the apparatus was recorded for each animal. The trial was terminated in cases where the mouse clutched the beam without walking, for five consecutive turns, or a maximum of 300 s had elapsed (16, 79, 80) .
Beam and Rod Walking (PNDs 88-92 and 152 for females, 60-64 and 95 for males).
A beam-walking motor task was conducted as previously described (41) . Square dowels of 59 cm in length were suspended 68 cm above a cushioned landing pad. A goal box at the end of the beam consisted of a 12 cm diameter cylinder to provide motivation to cross the beam. Each mouse was placed at the end of the beam and the time to cross to the goal box on the other end was measured. On the day prior to testing, all animals were given four practice trials on the largest diameter square beam in order to become accustom to the procedure (83) . On the test day, each animal was sequentially tested on three square beams (24 mm, 19 mm and 15 mm) and three round rods (17 mm, 12 mm and 9 mm). Testing sequence was based on presentations of decreasing diameter to present increasing levels of difficulty. Each mouse was given two trials on each beam, separated by ∼30 min. The time to transverse the beam was recorded and averaged across the two trials for each beam. A maximum time of 60 s was assigned to individuals that failed to cross the beam in that duration. In the small number of cases where mice fell from the beam, a score of 60 s was assigned.
Social Approach (PNDs 74-78 in females). Sociability was assessed using the three-chambered social approach task as previously described (80, 84, 85) . The testing apparatus consisted of three connected chambers made of white matte Plexiglas, separated by two sliding doors. Prior to testing, the subject mouse was placed in the empty center chamber with the doors closed for 5 min. Doors were then removed to allow free access to all three empty chambers for 10 min. Distance traveled and the number of entries into the two side chambers were automatically scored using three-point tracking with EthoVison XT tracking software (Noldus Information Technology Inc. Leesburg, VA). The mouse was then confined to the center chamber and a novel female 129Sv/ImJ mouse was placed in an inverted wire pencil cup in one chamber. An empty inverted wire pencil cup was simultaneously placed in the other chamber, to serve as the novel object. The partition doors were opened and the subject mouse was given free access to all three chambers for 10 min. Time spent and number of entries into each chamber, time spent sniffing the novel mouse and time the novel object and the total distance traveled were simultaneously scored using EithoVision XT (80, 84, 86) .
Short-term Memory Novel Object Recognition and Object Location Recognition (PNDs 66-71 and 81-85 in females) and (PNDs 39-44 and 47-52 in males)
. Novel object recognition testing was performed as described previously (16, 43, 87) . Briefly, all animals were handled for 2 min per day by the experimenter for 3 days. All animals were then habituated to the empty training arena for 10 min per day for 4 days. Distance travelled was recorded for each day of habituation and during training and testing. For the training session, each animal was placed into the arena with two identical objects for 10 min. A 5 min testing session occurred 60 min after training. For novel object recognition testing, one of the training objects was replaced with a novel object. For object location recognition testing, one of the training objects was placed in a novel location. Time spent exploring each object was scored by an experimenter blind to all conditions. Animals exploring less than 3 s total for both objects during training or testing were excluded from further analysis (88) .
Energy expenditure, food intake and physical activity (PND 88 in females and PNDs 57-66 in males). CLAMS analysis was performed on five separate sub-cohorts of Mecp2e1 mutant and control female and male mice (Supplementary Material, Table  S10 ). CLAMS analysis was performed on mice prior to significant changes in body weights and phenotypic scores between the two genotypes of each sex, hence the different time points in males and females. Mecp2e1 -/+ females (N = 11) and Mecp2e1 +/+ females (N = 12) were examined at PND 88 on day 0 of testing.
Mecp2e1
-/y males (N = 8) and Mecp2e1 +/y control males (N = 9)
were tested at PND 57-66 on day 0 of testing. On day 0, mice were transferred to single chamber housing in CLAMS chambers (Columbus Instruments, Columbus, OH) for acclimation for 48 h, and then data was analyzed from the subsequent 48 h of CLAMS measurements. On day 1, mice in CLAMS chambers were transferred to a temperature controlled cabinet set to 24
• C at 9:00 a.m. DEXA analysis. On day 5, mice were removed from CLAMS chambers at 9 a.m. and euthanized by isoflurane inhalation prior to body composition analysis by DEXA. Percent fat, total fat mass, BMC, BMD, bone area and subject length were calculated from absorption of the two X-ray frequencies.
Untargeted complex lipid analysis of liver. Liver samples from Mecp2e1 -/+ females (N = 8) and Mecp2e1 +/+ females (N = 7)
were flash frozen in RNA Later (Qiagen, Germantown, MD) immediately following the DEXA procedure for lipidomics. The untargeted lipidomics procedure began with lipid extraction from liver samples using methyl tert-butyl ether (MTBE) with the addition of internal standards, followed by ultra-high pressure liquid chromatography on a Waters CSH column, interfaced to a Q-TOF mass spectrometer (high resolution, accurate mass), with a 15 min total run time. Data are collected in both positive and negative ion mode and analyzed using Mass-Hunter (Agilent, Santa Clara, CA). Extraction of hepatic lipids was based on the "Matyash" method 36 LC/MS parameters. The LC/QTOFMS analyses were performed using an Agilent 1290 Infinity LC system (G4220A binary pump, G4226A autosampler and G1316C Column Thermostat) coupled to either an Agilent 6530 (positive ion mode) or an Agilent 6550 mass spectrometer equipped with an ion funnel (iFunnel) (negative ion mode). Lipids were separated on an Acquity UPLC CSH C18 column (100 × 2.1 mm; 1. .0007 m/z in negative mode was used for continuous mass correction. For the 6550, the reference solution was introduced via a dual spray ESI, with the same ions and continuous mass correction. Samples were injected (1.7 uls in positive mode and 5 uls in negative ion mode) with a needle wash for 20 s (wash solvent was isopropanol). The valve was switched back and forth during the run for washing, which has been shown to be essential for reducing carryover of less polar lipids.
Untargeted Lipidomics Data Analysis. For data processing, the MassHunter software was used, and a unique ID was given to each lipid based on its retention time and exact mass (RT mz). This allows the report of peak areas/heights or concentration of lipids based on the use of particular internal standards. Lipids are identified based on their unique MS/MS fragmentation patterns using in-house software, Lipidblast. Using complex lipid class-specific internal standards this approach was used to quantify > 400 lipid species including the following: mono-, di-and triacylglycerols, glycerophospholipids, sphingolipids, cholesterol esters, ceramides and fatty acids. Peak area/heights (intensity) data was recorded from the MS/MS data.
Metaboanalyst analysis. MetaboAnalyst 4.0 was used for analysis of QTOF-MS/MS peak intensity data. Settings for MetaboAnalyst (http://www.metaboanalyst.ca/) analysis were as follows: data filtering using interquantile range, sample normalization by sum, data transformation using log and Pareto scaling. Sample groups were considered to be unpaired. For fold change (FC) analysis, Mecp2e1 -/+ (MUTANT) peak heights over Mecp2e1 +/+ wild-type peak heights with a cutoff of log2 FC at > 1.0 or < 1.0 was used.
Statistical analyses of the data. Male and female developmental milestone data were analyzed separately. Continuous outcomes (body weight, body length and average righting reflex time) were analyzed using linear mixed effects models, including fixed effects for genotype, time and litter size (number of pups); the interaction genotype x time interaction; and random intercepts for mouse and litter (nlme and lsmeans R packages). Categorical ratings of pinnae detachment, eye opening, incisor eruption and fur development were analyzed using mixed effects Cox proportional hazards models of the time to full development; these models included fixed effects for genotype and litter size and a random slope for litter (coxme and car R packages). Categorical ratings of cliff avoidance, auditory startle, negative geotaxis, bar holding, vertical screen and level screen were analyzed using global F tests from regression models for ordinal data via cumulative link (mixed) models (clmm function from Ordinal R package) with fixed effects for genotype, time and litter size as well as the genotype x time interaction and random intercepts for mouse and litter. For males auditory startle ratings on the first time of assessment were not variable enough for inclusion in the model. For level screen scores, there was insufficient variability in scores for males beyond day 14 and for females beyond day 12 so only the first four or three time points were analyzed, respectively. Post-weaning weight was analyzed separately for each sex using a linear mixed effects model, including fixed effects for genotype, time, genotype x time interaction and random effect of mouse. Benjamini-Hochberg corrected post-hoc comparisons were made for each time point. The development of significant hind limb clasping in the mutant mice was assessed for each time point where at least one animal showed a non-zero clasping score. At each time point examined, the number of animals with non-zero clasping scores was assessed using a binomial test (R package binom, with the binom.confint function with twosided test) to assess if clasping was significantly greater than zero (no clasping) with an overall Benjamini-Hochberg correction across time points.
All other behavioral analyses included parametric independent, two-tailed t-tests or ANOVA models with BenjaminiHochberg-corrected multiple post-hoc tests. Repeated measures tasks were accessed using a mixed model repeated measures ANOVA with a repeated measure and genotype and fostering as factors. All analyses were conducted using R, version 3.3.1 (89) or prism version 7. Linear mixed effects modeling was conducted using the R package lme4, version 1.1-12 (90), or nlme, version 3.1-131.1 (91) with lsmeans, version 2.27-61 (92) , mixed effects Cox proportional hazards modeling was conducted using the R package coxme, version 2.2-5 (93) and mixed effects proportional odds logistic regression modeling was conducted using the R packages ordinal, version 2015.6-28 (94) .
For CLAMS and DEXA analysis, all data are expressed as mean ± SEM unless otherwise indicated. Differences within a group were evaluated by t-test while differences between genotypes and sexes were evaluated using a two-way ANOVA (95) . Post-hoc analysis was carried out using a Tukey's honest significant difference test. For energy expenditure data, ANCOVA was used with either body weight or lean mass as a covariate in the model.
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